Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status.

Por Smith-Sørensen, B., Kaern, J., Holm, R., Dørum, A., Tropé, C., Børresen-Dale, A. L.
Publicado em 1998

Interferon-γ suppresses S100A4 transcription independently of apoptosis or cell cycle arrest

Por Andersen, K, Smith-Sørensen, B, Pedersen, K B, Hovig, E, Myklebost, O, Fodstad, Ø, Mælandsmo, G M
Publicado em 2003

Database of p53 gene somatic mutations in human tumors and cell lines.

Por Hollstein, M, Rice, K, Greenblatt, M S, Soussi, T, Fuchs, R, Sørlie, T, Hovig, E, Smith-Sørensen, B, Montesano, R, Harris, C C
Publicado em 1994

p16(INK4A) as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy

Por Geisler, S, Smith-Sørensen, B, Betticher, D, Bukholm, IK, Akslen, LA, Kappeler, A, Gugger, M, Lønning, PE, Børresen-Dale, A-L
Publicado em 2000

Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.

Por Børresen, A L, Hovig, E, Smith-Sørensen, B, Malkin, D, Lystad, S, Andersen, T I, Nesland, J M, Isselbacher, K J, Friend, S H
Publicado em 1991